Insider Transactions Reported by 19 Insiders of Opus Genetics, Inc.

Symbol
IRD on Nasdaq
Location
Durham, NC

Insiders trading volume in the past year

Opus Genetics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Foundation Fighting Blindness Retinal Degeneration Fund Director, Other* $11,808,167 -$8,600,000 -42% 09 Dec 2025
Cam Gallagher Director $4,708,956 +$323,693 +7.4% 06 Jan 2026
George Magrath Chief Executive Officer, Director $3,568,338 22 Jan 2026
Ashwath Jayagopal Chief Scientific & Dev. Ofc. $1,764,474 12 Feb 2026
Benjamin R. Yerxa President, Director $1,445,200 22 Jan 2026
Robert E. Gagnon Chief Financial Officer $1,206,000 22 Jan 2026
Sean Ainsworth Director $674,927 01 Jan 2026
James S. J. Manuso Director $664,998 01 Jan 2026
Joseph K. Schachle Chief Operating Officer $612,045 22 Jan 2026
Jean Bennett Director $532,660 01 Jan 2026
Rabourn Amy Zaremba Head of Fin. Quality Assurance $388,187 22 Jan 2026
Jay Pepose Director $318,508 11 Jun 2024
Ronil A. Patel Chief Business Officer $296,181 10 Jan 2024
Richard J. Rodgers Director $283,602 30 Apr 2025
Adrienne L. Graves Director $234,143 01 Jan 2026
Nirav S. Jhaveri Chief Financial Officer $223,437 13 Mar 2025
Bernhard Hoffmann SVP of Corp. Dev. $213,263 13 Mar 2025
Susan Benton Director $195,379 30 Apr 2025
Mina Sooch President and CEO, Director $163,250 10 Jan 2023

Recent Insider Transactions by Companies or Individuals for Opus Genetics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Ashwath Jayagopal IRD Common Stock Tax liability -1.01% -5,313 520,494 12 Feb 2026 Direct
Rabourn Amy Zaremba IRD Common Stock Award 81.1% 86,500 193,128 22 Jan 2026 Direct
George Magrath IRD Common Stock Award 37.4% 483,639 1,775,293 22 Jan 2026 Direct
Ashwath Jayagopal IRD Common Stock Award 318% 400,000 525,807 22 Jan 2026 Direct
Robert E. Gagnon IRD Common Stock Award 200% 400,000 600,000 22 Jan 2026 Direct
Joseph K. Schachle IRD Common Stock Award 458.7% 250,000 304,500 22 Jan 2026 Direct
Benjamin R. Yerxa IRD Common Stock Award 125.4% 400,000 719,005 22 Jan 2026 Direct
Rabourn Amy Zaremba IRD Common Stock Tax liability -3.08% -3,390 106,628 18 Jan 2026 Direct
Rabourn Amy Zaremba IRD Common Stock Tax liability -3.47% -3,950 110,018 10 Jan 2026 Direct
Cam Gallagher IRD Common Stock Award 3.48% 67,000 1,991,430 06 Jan 2026 Direct
James S. J. Manuso IRD Common Stock Award 11.9% 31,188 292,951 01 Jan 2026 Direct
Adrienne L. Graves IRD Common Stock Award 29.7% 23,643 103,147 01 Jan 2026 Direct
Jean Bennett IRD Common Stock Award 9.89% 21,127 234,652 01 Jan 2026 Direct
Sean Ainsworth IRD Common Stock Award 16.7% 42,507 297,325 01 Jan 2026 Direct
Cam Gallagher IRD Common Stock Award 1.74% 33,000 1,924,430 31 Dec 2025 Direct
Cam Gallagher IRD Common Stock Purchase $163,419 $1.97 83,000 83,000 29 Dec 2025 By Garret Gallagher - Custodian UTMA/UGMA
Cam Gallagher IRD Common Stock Purchase 4.47% $160,275 $1.98 81,000 1,891,430 29 Dec 2025 Direct
Foundation Fighting Blindness Retinal Degeneration Fund IRD Common Stock Sale -42.1% $8,600,000 $2.15 -4,000,000 5,492,171 09 Dec 2025 Direct
George Magrath IRD Common Stock Tax liability -2.3% -30,350 1,291,654 01 Nov 2025 Direct
Benjamin R. Yerxa IRD Common Stock Tax liability -6.94% -23,795 319,005 22 Oct 2025 Direct
Robert E. Gagnon IRD Common Stock Award 200,000 200,000 10 Sep 2025 Direct
Robert E. Gagnon IRD Employee Stock Option (right to buy) Award 250,000 250,000 02 Sep 2025 Direct
Cam Gallagher IRD Common Stock Award 92.4% 869,565 1,810,430 25 Aug 2025 Direct
Sean Ainsworth IRD Common Stock Award 51.8% 86,956 254,818 25 Aug 2025 Direct
Foundation Fighting Blindness Retinal Degeneration Fund IRD Common Stock Conversion of derivative security 270.1% 6,927,419 9,492,171 05 May 2025 Direct
Foundation Fighting Blindness Retinal Degeneration Fund IRD Series A Non-Voting Convertible Preferred Stock Conversion of derivative security -100% -6,927 0 05 May 2025 Direct
Richard J. Rodgers IRD Common Stock Award 33.2% 79,504 318,655 30 Apr 2025 Direct
Richard J. Rodgers IRD Stock Option (Right to Buy) Award 79,592 79,592 30 Apr 2025 Direct
James S. J. Manuso IRD Common Stock Award 43.6% 79,504 261,763 30 Apr 2025 Direct
James S. J. Manuso IRD Stock Option (Right to Buy) Award 79,592 79,592 30 Apr 2025 Direct
Adrienne L. Graves IRD Common Stock Award 79,504 79,504 30 Apr 2025 Direct
Adrienne L. Graves IRD Stock Option (Right to Buy) Award 79,592 79,592 30 Apr 2025 Direct
Cam Gallagher IRD Common Stock Award 9.23% 79,504 940,865 30 Apr 2025 Direct
Cam Gallagher IRD Stock Option (Right to Buy) Award 79,592 79,592 30 Apr 2025 Direct
Susan Benton IRD Common Stock Award 56.8% 79,504 219,527 30 Apr 2025 Direct
Susan Benton IRD Stock Option (Right to Buy) Award 79,592 79,592 30 Apr 2025 Direct
Jean Bennett IRD Common Stock Award 59.3% 79,504 213,525 30 Apr 2025 Direct
Jean Bennett IRD Stock Option (Right to Buy) Award 79,592 79,592 30 Apr 2025 Direct
Sean Ainsworth IRD Common Stock Award 90% 79,504 167,862 30 Apr 2025 Direct
Sean Ainsworth IRD Stock Option (Right to Buy) Award 79,592 79,592 30 Apr 2025 Direct
George Magrath IRD Common Stock Award 42.2% 392,157 1,322,004 24 Mar 2025 Direct
George Magrath IRD Warrants (right to buy) Award 392,157 392,157 24 Mar 2025 Direct
Cam Gallagher IRD Common Stock Award 1018% 784,314 861,361 24 Mar 2025 Direct
Cam Gallagher IRD Warrants (right to buy) Award 784,314 784,314 24 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.